Blinded by rare disorder, Alberta man fundraising to regain vision

Related Posts

26 May

Is The “Tinder-fication” Of Online Dating Over? S’More Thinks So, And Has The Data To Back It Up

New data gathered by the dating app company S’More suggests that their unique approach to online dating — one…

read more
15 Jan

Odessa man’s vision changed by electronic glasses

Nick Flores, 23, received electronic glasses from eSight this past October to help enhance his vision. Read more >>

read more
21 Nov

Watch as legally blind boy sees clearly for the first time

This Thanksgiving, gratitude is being served us as never before by one Sandusky family. It’s the first holiday, the…

read more
15 Nov

Emovi, Inc. Partners with Laurent Duvernay-Tardif, Kansas City Chiefs’ Right Guard and McGill Medical School Graduate

Emovi, Inc. signed a multiyear endorsement agreement with Kansas City Chiefs guard Laurent Duvernay-Tardif, MDCM to help support knowledge…

read more
17 Jan

Regroup Mass Notification Named Finalist in Disaster Recovery Institute’s 2020 Awards of Excellence

Regroup Mass Notification provider of a powerful emergency and day-to-day mass communication solutions, today announced that it has been…

read more
03 Jun

LaunchPad Medical Wins a Coveted $1.8 Million Michigan-Pittsburgh-Wyss Regenerative Medicine Center Grant

LaunchPad Medical, Inc. announced that it has received follow-on support of up to $1.8 million from the Michigan-Pittsburgh-Wyss Regenerative…

read more
12 Feb

Advancing Platelet-Based Therapeutics for Patients

Platelet BioGenesis (PBG) reports that it is working with the Canadian Centre for Commercialization of Regenerative Medicine (CCRM) and…

read more
24 Apr

Biotech Firm KnipBio and Biofuels Leader ICM Inc. Ink Collaboration

KnipBio, Inc. and ICM, Inc. announce today that the companies have entered into a joint development agreement (JDA) and…

read more
18 Jan

Corbus Pharmaceuticals Receives Orphan Designation for JBT-101 for the Treatment of Systemic Sclerosis in the European Union

Corbus Pharmaceuticals Holdings, Inc. (CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious…

read more
02 May

Siamab Therapeutics Announces Publication of New Data on its ST1 Lead Program in the Journal Oncotarget

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced the publication of new preclinical data…

read more